Based on the iShares Trust - iShares Neuroscience and Healthcare ETF stock forecast from 0 analysts, the average analyst target price for iShares Trust - iShares Neuroscience and Healthcare ETF is not available over the next 12 months. iShares Trust - iShares Neuroscience and Healthcare ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of iShares Trust - iShares Neuroscience and Healthcare ETF is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, iShares Trust - iShares Neuroscience and Healthcare ETF’s stock price was USD 26.50. iShares Trust - iShares Neuroscience and Healthcare ETF’s stock price has changed by +2.34% over the past week, -2.58% over the past month and +26.56% over the last year.
No recent analyst target price found for iShares Trust - iShares Neuroscience and Healthcare ETF
No recent average analyst rating found for iShares Trust - iShares Neuroscience and Healthcare ETF
Company Overview iShares Trust - iShares Neuroscience and Healthcare ETF
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index. It is non-diversified. Read Less
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, opti...Read More
N/A
N/A
N/A
N/A
USD
USA
N/A
N/A
N/A
0.47 %
Adjusted Closing Price for iShares Trust - iShares Neuroscience and Healthcare ETF (IBRN)
Loading...
Unadjusted Closing Price for iShares Trust - iShares Neuroscience and Healthcare ETF (IBRN)
Loading...
Share Trading Volume for iShares Trust - iShares Neuroscience and Healthcare ETF Shares
Loading...
Compare Performance of iShares Trust - iShares Neuroscience and Healthcare ETF Shares
Frequently Asked Questions About iShares Trust - iShares Neuroscience and Healthcare ETF (IBRN) Stock
Stock Target Advisor's fundamental analysis for iShares Trust - iShares Neuroscience and Healthcare ETF's stock is Very Bearish.
IBRN stock's dividend yield is 0.03%.
Our analysis grades IBRN stock's dividend yield at F. This means that IBRN stock's dividend yield is above 2% of the stocks in the Others sector in the NYE exchange.
Based on this IBRN may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on IBRN's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on IBRN's stock to indicate if its overvalued.
The last closing price of IBRN's stock was USD 26.50.
The most recent market capitalization for IBRN is USD 4.01M.
Unfortunately we do not have enough analyst data on IBRN's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains iShares Trust - iShares Neuroscience and Healthcare ETF's stock.
Sorry, we do not have any data on the number of employees for iShares Trust - iShares Neuroscience and Healthcare ETF.
Sorry we do not have any infomation available on iShares Trust - iShares Neuroscience and Healthcare ETF's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Frequently Asked Questions About iShares Trust - iShares Neuroscience and Healthcare ETF (IBRN) Stock
Stock Target Advisor's fundamental analysis for iShares Trust - iShares Neuroscience and Healthcare ETF's stock is Very Bearish.
IBRN stock's dividend yield is 0.03%.
Our analysis grades IBRN stock's dividend yield at F. This means that IBRN stock's dividend yield is above 2% of the stocks in the Others sector in the NYE exchange.
Based on this IBRN may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on IBRN's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on IBRN's stock to indicate if its overvalued.
The last closing price of IBRN's stock was USD 26.50.
The most recent market capitalization for IBRN is USD 4.01M.
Unfortunately we do not have enough analyst data on IBRN's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains iShares Trust - iShares Neuroscience and Healthcare ETF's stock.
Sorry, we do not have any data on the number of employees for iShares Trust - iShares Neuroscience and Healthcare ETF.
Sorry we do not have any infomation available on iShares Trust - iShares Neuroscience and Healthcare ETF's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for IBRN !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
